Cardiovascular system pharmacology
... - pharmacological effects of digitalis:- the most important property of cardiac glycosides is their positive inotropic effect , that is , their ability to ↑ the force of myocardial contraction .The result is ↑ed cardiac work at reduced metabolic cost. - digitalis also have effects on electrophysical ...
... - pharmacological effects of digitalis:- the most important property of cardiac glycosides is their positive inotropic effect , that is , their ability to ↑ the force of myocardial contraction .The result is ↑ed cardiac work at reduced metabolic cost. - digitalis also have effects on electrophysical ...
STRUCTURAL ACTIVITY RELATIONSHIP AMONG THE
... •Cause skeletal muscle contractions •Used for diagnosis and treatment of myasthenia gravis •Used to reverse neuromuscular blocking ...
... •Cause skeletal muscle contractions •Used for diagnosis and treatment of myasthenia gravis •Used to reverse neuromuscular blocking ...
File - Doctorswriting
... B. For drugs used at concentrations which give a maximal response C. For drugs which have delayed distribution D. All of the above E. None of the above 24. Calcium channel blockers A. Dihydropyridines are less cardioselective and more vascularly active when compared to other groups B. Results in inc ...
... B. For drugs used at concentrations which give a maximal response C. For drugs which have delayed distribution D. All of the above E. None of the above 24. Calcium channel blockers A. Dihydropyridines are less cardioselective and more vascularly active when compared to other groups B. Results in inc ...
Hypertension
... Drug(s) for the compelling indications. other antihyperte nsive drugs (diuretics, ACEI, ARB, BB, CCB) as needed. ...
... Drug(s) for the compelling indications. other antihyperte nsive drugs (diuretics, ACEI, ARB, BB, CCB) as needed. ...
Preliminary Study of Blood Pressure Lowering Effect of Anredera
... reduce increasing in adrenalin-induced heart rate. This result similar with administration of EEBL. Moreover, EEBL gave lower increasing in heart rate than atenolol group (standard group) and adrenalin group (positive control group). Based on this result, it can be suggested that EEBL can reduce the ...
... reduce increasing in adrenalin-induced heart rate. This result similar with administration of EEBL. Moreover, EEBL gave lower increasing in heart rate than atenolol group (standard group) and adrenalin group (positive control group). Based on this result, it can be suggested that EEBL can reduce the ...
Chapter 16 Cholinesterase Inhibitors
... Block access of angiotensin II Cause dilation of arterioles and veins Prevent angiotensin II from inducing pathologic changes in cardiac structure Reduce excretion of potassium Decrease release of aldosterone Increase renal excretion of sodium and water Do not inhibit kinase II Do not increase level ...
... Block access of angiotensin II Cause dilation of arterioles and veins Prevent angiotensin II from inducing pathologic changes in cardiac structure Reduce excretion of potassium Decrease release of aldosterone Increase renal excretion of sodium and water Do not inhibit kinase II Do not increase level ...
Headache HeadacheForum May 29
... Consider coexisting conditions: The Coexisting diseases present both treatment opportunities and limitations. ...
... Consider coexisting conditions: The Coexisting diseases present both treatment opportunities and limitations. ...
`optimal medical therapy`? The case of chronic heart failure
... firstly by recording drug doses used in clinical practice. These may result from beliefs and behaviours of physicians in prescribing drugs or from beliefs of patients on their effectiveness and safety in taking them. Secondly, long-term observational registries can be designed to clarify the reasons ...
... firstly by recording drug doses used in clinical practice. These may result from beliefs and behaviours of physicians in prescribing drugs or from beliefs of patients on their effectiveness and safety in taking them. Secondly, long-term observational registries can be designed to clarify the reasons ...
CATECHOLAMINES - Drexel University College of Medicine
... Hsiao, M.D., for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators* ...
... Hsiao, M.D., for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators* ...
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
... danger of foetal renal maldevelopment. Like ACE inhibitor treatment, regimens based on ARBs reduce the risk of new onset diabetes. ...
... danger of foetal renal maldevelopment. Like ACE inhibitor treatment, regimens based on ARBs reduce the risk of new onset diabetes. ...
the use of cardiovascular drugs in niš region of
... The predominance of cardiovascular drugs (53%) in total drug utilization volume is a consequence of high cardiovascular morbidity and mortality. Out of the total volume of cardiovascular drugs, the outpatients used ACE inhibitors the most, especially enalapril. This could be explained by widening of ...
... The predominance of cardiovascular drugs (53%) in total drug utilization volume is a consequence of high cardiovascular morbidity and mortality. Out of the total volume of cardiovascular drugs, the outpatients used ACE inhibitors the most, especially enalapril. This could be explained by widening of ...
Assist professor Hayder M. Alkuraishy PROKINETIC and
... tract motility. Therefore, 5-HT4 receptors have been identified as potential therapeutic targets for diseases related to GI dysmotility such as chronic constipation. Some of these prokinetic agents, such as mosapride and cisapride, have only moderate affinity for 5HT4 receptors. Prucalopride, is a s ...
... tract motility. Therefore, 5-HT4 receptors have been identified as potential therapeutic targets for diseases related to GI dysmotility such as chronic constipation. Some of these prokinetic agents, such as mosapride and cisapride, have only moderate affinity for 5HT4 receptors. Prucalopride, is a s ...
Psychopharmacology - Ohio State University
... “anxiolytics” increase GABA-A receptor activity in the CNS This potentiation of GABA produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects. ...
... “anxiolytics” increase GABA-A receptor activity in the CNS This potentiation of GABA produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects. ...
ANTIPSYCHOTICS
... 12) Known poor CYP2D6 metabolizer 13) Concomitant use with drugs that inhibit thioridazine metabolism (fluvoxamine, propranolol, pindolol) 14) Concomitant use with drugs that inhibit CYP2D6 (fluoxetine, paroxetine) Relative: 1) Pregnancy/nursing mothers 2) History of drug induced agranulocytosis or ...
... 12) Known poor CYP2D6 metabolizer 13) Concomitant use with drugs that inhibit thioridazine metabolism (fluvoxamine, propranolol, pindolol) 14) Concomitant use with drugs that inhibit CYP2D6 (fluoxetine, paroxetine) Relative: 1) Pregnancy/nursing mothers 2) History of drug induced agranulocytosis or ...
Pharmacology of the Autonomic Nervous System
... (dopamine, histamine, serotonin, adenosine, PGD2, PGE2 and acetylcholine via a muscarinic receptor) norepinephrine release in selected tissues. Released catecholamines may a) be retaken up into the neuron (norepinephrine transporter or uptake I), b) be taken up by the extraneuronal tissue (uptake II ...
... (dopamine, histamine, serotonin, adenosine, PGD2, PGE2 and acetylcholine via a muscarinic receptor) norepinephrine release in selected tissues. Released catecholamines may a) be retaken up into the neuron (norepinephrine transporter or uptake I), b) be taken up by the extraneuronal tissue (uptake II ...
Pharmacological Management of Congestive Heart Failure
... Atrial extra-systole flutter fibrillation Ventricular extra-systole tachycardia fibrillation Partial heart block complete block ...
... Atrial extra-systole flutter fibrillation Ventricular extra-systole tachycardia fibrillation Partial heart block complete block ...
Medicinal Lecture
... -nitrogen to sulfurnot acceptable; different interaction with the receptor. Enol form -convert to ether group, by removing oxygen number 2 (ethers are more resistant to metabolism). -Add chloride to the nitrogen groupnot acceptable because addition ...
... -nitrogen to sulfurnot acceptable; different interaction with the receptor. Enol form -convert to ether group, by removing oxygen number 2 (ethers are more resistant to metabolism). -Add chloride to the nitrogen groupnot acceptable because addition ...
Angiotensin Receptor Blockade and New
... that blockade of the RAS provides end-organ protection above and beyond blood pressure reduction is well established although it has been challenged by a recent meta-analysis 6 . Additional benefits in using angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) inclu ...
... that blockade of the RAS provides end-organ protection above and beyond blood pressure reduction is well established although it has been challenged by a recent meta-analysis 6 . Additional benefits in using angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) inclu ...
Basic concepts in clinical pharmacology
... 1. You are the OOH drug information scientist / pharmacist / GP / on-call officer for the pharmaceutical company / nurse / etc. 2. The (male) patient has a longstanding history of kidney stones. They are usually small, they usually pass within 48 h, and the patient has been responsibly using 10 mg m ...
... 1. You are the OOH drug information scientist / pharmacist / GP / on-call officer for the pharmaceutical company / nurse / etc. 2. The (male) patient has a longstanding history of kidney stones. They are usually small, they usually pass within 48 h, and the patient has been responsibly using 10 mg m ...
THE EXTENT OF POPULATION EXPOSURE TO ASSESS CLINICAL
... E) Any of the above designs with an active control drug Long-term studies to show efficacy (and which are also needed for assessment of long term safety) would usually use active controls, preferably with a placebo-controlled randomized withdrawal study at the end of treatment to establish assay sen ...
... E) Any of the above designs with an active control drug Long-term studies to show efficacy (and which are also needed for assessment of long term safety) would usually use active controls, preferably with a placebo-controlled randomized withdrawal study at the end of treatment to establish assay sen ...
1 The Neuromuscular Junction: Pharmacology
... the nicotinic acetylcholine receptor at NMJ: d-tubocurarine (a plant alkaloid in curare, a tree bark-extract used by Amazonian natives in manufacturer of poisoned hunting darts) and αbungarotoxin, a component of the venom of the Taiwanese banded krait, a poisonous snake. Tubocurarine is a reversible ...
... the nicotinic acetylcholine receptor at NMJ: d-tubocurarine (a plant alkaloid in curare, a tree bark-extract used by Amazonian natives in manufacturer of poisoned hunting darts) and αbungarotoxin, a component of the venom of the Taiwanese banded krait, a poisonous snake. Tubocurarine is a reversible ...
PowerPoint プレゼンテーション
... Vemurafenib: the first drug approved for BRAF-mutant cancer. Bollag G, Tsai J, Zhang J, Zhang C, Ibrahim P, Nolop K, Hirth P. Plexxikon, 91 Bolivar Drive, Berkeley, California 94710, USA. ...
... Vemurafenib: the first drug approved for BRAF-mutant cancer. Bollag G, Tsai J, Zhang J, Zhang C, Ibrahim P, Nolop K, Hirth P. Plexxikon, 91 Bolivar Drive, Berkeley, California 94710, USA. ...
Beta Blocker Newsletter
... complications, acutely and in the postinfarction period. Results from major trials show a reduction in overall mortality of more than 20-30%.6-9 â blockers with moderate to high lipophilicity (timolol, metoprolol, propranolol) have shown marked reductions in sudden cardiac death.7-9 It is postulated ...
... complications, acutely and in the postinfarction period. Results from major trials show a reduction in overall mortality of more than 20-30%.6-9 â blockers with moderate to high lipophilicity (timolol, metoprolol, propranolol) have shown marked reductions in sudden cardiac death.7-9 It is postulated ...
Adrenergic_antagonists
... circulating catecholamine can stimulate them & cause severe arrhythmia. So, withdrawal should be very gradual over ...
... circulating catecholamine can stimulate them & cause severe arrhythmia. So, withdrawal should be very gradual over ...